semaglutide patient information How Helps Patients Lose Weight Safely semaglutide patient education Looking to

According to NICE (2022) NG28 recommendations, those with type 2 diabetes on multiple daily insulin injections (MDI) who fulfil additional criteria (recurrent or severe hypoglycaemia, impaired hypoglycaemia awareness, would otherwise be advised to self-monitor capillary glucose at least eight times a day, or have a condition or disability that means they cannot self-monitor capillary blood glucose) would be eligible for CGM

Common side effects of GLP-1 agonists include gastrointestinal symptoms such as nausea, diarrhea, and abdominal pain

Do not store semaglutide directly against the back wall where cooling elements might cause localized freezing

While exenatide gained traction, Danish pharmaceutical company Novo Nordisk approached the challenge differently

Another, gastric bypass, similarly reduces stomach size but also bypasses part of the small intestine to decrease calorie absorption